Canaccord Genuity Maintains Hold on T2 Biosystems, Lowers Price Target to $3

T2 Biosystems, Inc. +10.46%

T2 Biosystems, Inc.

TTOO

5.49

+10.46%

Canaccord Genuity analyst Kyle Mikson maintains T2 Biosystems (NASDAQ: TTOO) with a Hold and lowers the price target from $12 to $3.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via